Suppr超能文献

局部晚期乳腺癌动脉内灌注化疗联合局部静脉阻断作为手术新辅助治疗的随访研究

The follow up study of intra-arterial infusion chemotherapy with local vein blocking as a surgical neo-adjuvant treatment for locally advanced breast cancer.

作者信息

Iwasa Z, Matsunami N, Saeki Y, Kurooka K, Yamato M, Okuno K, Sagara N, Matsuda T, Yasutomi M

机构信息

First Department of Surgery, Kinki University School of Medicine, Osaka, Japan.

出版信息

Jpn J Surg. 1988 Mar;18(2):131-5. doi: 10.1007/BF02471420.

Abstract

Preoperative intra-arterial infusion neo-adjuvant chemotherapy, in combination with local vein blocking, was administered to thirty-one patients with locally advanced stage III breast cancer. The anti-cancer drugs and dosages used were 500 mg of 5-Fluorouracil (5FU), which was infused daily for 7-14 days, and 20 mg of Adriamycin (ADM), which was administered as a bolus dose twice into the subclavian and internal mammary arteries. The response rate of this method on the primary tumor was 48.4 per cent, and, histologically it was found to be as high as 90.3 per cent. The response rate of the clinical effects on the regional lymph nodes was 50.0 per cent, however, histologically, it was found to be lower than that of the primary tumor. In the long-term follow-up study the 5-year survival rate was 72.2 per cent. Thus, this method seems to be effective as a combined modality in cases of locally advanced stage III breast cancer.

摘要

对31例局部晚期III期乳腺癌患者进行术前动脉内灌注新辅助化疗,并结合局部静脉阻断。使用的抗癌药物及剂量为:5-氟尿嘧啶(5FU)500mg,每日输注,持续7 - 14天;阿霉素(ADM)20mg,分两次大剂量注入锁骨下动脉和胸廓内动脉。该方法对原发肿瘤的有效率为48.4%,组织学有效率高达90.3%。对区域淋巴结临床疗效的有效率为50.0%,但组织学有效率低于原发肿瘤。在长期随访研究中,5年生存率为72.2%。因此,该方法作为局部晚期III期乳腺癌的联合治疗方式似乎是有效的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验